Federation des caisses Desjardins du Quebec’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$43.7K	Buy	4,586 +1,566	+52%	+$12.2K	﹤0.01%	1898
2025 Q4	$23.6K	Buy	3,020 +626	+26%	+$4.53K	﹤0.01%	2020
2025 Q3	$18.2K	Hold	2,394	–	–	﹤0.01%	2069
2025 Q2	$21.4K	Buy	+2,394	New	+$22.3K	﹤0.01%	1794
2021 Q3	–	Sell	-4,800	Closed	-$75.9K	–	2560
2021 Q2	$75.9K	Sell	4,800 -3,000	-38%	-$40.8K	﹤0.01%	1482
2021 Q1	$79.3K	Sell	7,800 -6,200	-44%	-$63.9K	﹤0.01%	1411
2020 Q4	$104K	Buy	+14,000	New	+$72.2K	﹤0.01%	1267
2020 Q3	–	Sell	-6,200	Closed	-$29.5K	–	2168
2020 Q2	$29.5K	Buy	+6,200	New	+$24.8K	﹤0.01%	1346
2018 Q2	–	Sell	-43,502	Closed	-$207K	–	2158
2018 Q1	$207K	Sell	43,502 -15,005	-26%	-$77.1K	﹤0.01%	1007
2017 Q4	$287K	Hold	58,507	–	–	﹤0.01%	953
2017 Q3	$307K	Buy	58,507 +24,619	+73%	+$126K	﹤0.01%	907
2017 Q2	$188K	Buy	+33,888	New	+$206K	﹤0.01%	1020